Given the association between a disturbed bioenergetic metabolism and the onset and progression of AD and the fact that the MT moiety enhances mitochondrial function, we aimed to determine whether the negative interaction between cholinesterase inhibitors and HMTM might be caused by changes in the oxidative phosphorylation/glycolytic profile of the brain. Here, BCHE is linked to Alzheimer disease.